title: Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole.
authors.affiliation: Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Bayers
authors.forename: Lisa
authors.initials: L
authors.lastname: Arkin
authors.forename: Benjamin
authors.initials: B
authors.lastname: Bohaty
authors.forename: Amy S
authors.initials: AS
authors.lastname: Paller
mesh_terms: D000293:Adolescent; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology; D018570:Risk Assessment
chemical_list: D017964:Itraconazole; D016572:Cyclosporine